G
Genpact Limited NYSE$34.14
Mkt Cap $5.8B
52w Low $33.14
5.8% of range
52w High $50.24
50d MA $37.45
200d MA $41.92
P/E (TTM)
10.8x
EV/EBITDA
10.3x
P/B
2.3x
Debt/Equity
0.7x
ROE
21.7%
P/FCF
11.1x
RSI (14)
—
ATR (14)
—
Beta
0.75
50d MA
$37.45
200d MA
$41.92
Avg Volume
2.6M
About
Genpact Limited provides business process outsourcing and information technology (IT) services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Banking, Capital Markets and Insurance; Consumer Goods, Retail, Life Sciences and Healthcare; and High Tech, Manufacturing and Services. The company offers CFO advisory services; and environmental, social, an…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 5, 2026 | AMC | 0.93 | 0.97 | +4.3% | 37.70 | +3.4% | +7.1% | +4.7% | +3.8% | -1.4% | -3.7% | — |
| Nov 6, 2025 | AMC | 0.90 | 0.97 | +8.0% | 38.39 | +12.2% | +15.9% | +15.3% | +16.9% | +18.6% | +17.3% | — |
| Aug 7, 2025 | AMC | 0.85 | 0.88 | +3.5% | 41.72 | +0.8% | +4.4% | +3.7% | +3.8% | +6.0% | +4.7% | — |
| May 7, 2025 | AMC | 0.80 | 0.84 | +5.0% | 49.55 | -15.3% | -15.2% | -14.3% | -12.1% | -11.8% | -12.8% | — |
| Feb 6, 2025 | AMC | 0.86 | 0.91 | +5.8% | 49.40 | +11.2% | +11.2% | +10.2% | +10.9% | +11.1% | +12.4% | — |
| Nov 7, 2024 | AMC | 0.80 | 0.85 | +6.2% | 41.81 | +8.1% | +9.9% | +11.6% | +11.6% | +9.8% | +7.9% | — |
| Aug 8, 2024 | AMC | 0.72 | 0.72 | +0.0% | 32.40 | +12.2% | +15.7% | +12.8% | +15.9% | +16.0% | +18.0% | — |
| May 9, 2024 | AMC | 0.68 | 0.73 | +7.4% | 32.05 | +4.0% | +3.6% | +5.8% | +6.3% | +7.6% | +7.4% | — |
| Feb 8, 2024 | AMC | 0.74 | 0.82 | +10.8% | 34.94 | +3.0% | +4.6% | +3.2% | +0.4% | +2.0% | +2.8% | — |
| Nov 8, 2023 | AMC | 0.73 | 0.76 | +4.1% | 34.75 | -8.4% | -9.1% | -7.1% | -7.9% | -3.7% | -3.5% | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 10 | Mizuho | Maintains | Neutral → Neutral | — | $39.49 | $39.55 | +0.2% | -0.9% | -5.8% | -8.1% | -5.4% | -4.5% |
| Feb 6 | Needham | Maintains | Buy → Buy | — | $37.70 | $38.99 | +3.4% | +7.1% | +4.7% | +3.8% | -1.4% | -3.7% |
| Aug 20 | JP Morgan | Maintains | Neutral → Neutral | — | $44.79 | $44.77 | -0.0% | -1.7% | -0.6% | +1.2% | +1.5% | +0.7% |
| Aug 8 | Needham | Maintains | Buy → Buy | — | $41.72 | $42.06 | +0.8% | +4.4% | +3.7% | +3.8% | +6.0% | +4.7% |
| Jul 1 | Mizuho | Maintains | Neutral → Neutral | — | $44.01 | $44.06 | +0.1% | +2.2% | +2.2% | +4.3% | +4.7% | +4.8% |
| Jun 30 | Needham | Maintains | Buy → Buy | — | $43.54 | $43.80 | +0.6% | +1.1% | +3.3% | +3.3% | +5.5% | +5.8% |
| Jun 27 | TD Cowen | Maintains | Buy → Buy | — | $42.25 | $43.59 | +3.2% | +3.1% | +4.2% | +6.4% | +6.5% | +8.7% |
| May 8 | Needham | Maintains | Buy → Buy | — | $49.55 | $41.96 | -15.3% | -15.2% | -14.3% | -12.1% | -11.8% | -12.8% |
| May 8 | Baird | Maintains | Neutral → Neutral | — | $49.55 | $41.96 | -15.3% | -15.2% | -14.3% | -12.1% | -11.8% | -12.8% |
| Feb 10 | Mizuho | Maintains | Neutral → Neutral | — | $54.95 | $54.93 | -0.0% | -0.9% | -0.3% | -0.1% | +1.1% | +0.2% |
Recent Filings
8-K
GENPACT LIMITED -- 8-K Filing
I cannot provide a meaningful investor summary for this filing, as the document content provided contains only technical XBRL metadata and references rather than substantive business information about Genpact Limited.
Apr 29
8-K
Kyndryl Holdings, Inc. -- 8-K Filing
Kyndryl Holdings appointed an executive with extensive financial leadership experience from Genpact, strengthening its corporate governance and accounting oversight capabilities.
Feb 9
8-K
GENPACT LIMITED -- 8-K Filing
Genpact's Advanced Technology Solutions segment achieved 17% year-over-year growth, driven by expanding data, AI, and agentic solutions, signaling strong momentum in high-margin offerings.
Feb 5
Data updated apr 25, 2026 10:34am
· Source: massive.com